SynthesisFrontiers in immunology2025

Addition of immunotherapy to perioperative chemotherapy for resectable gastric and gastroesophageal junction cancer: a meta-analysis of phase 2/3 trials.

Yuxuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.